Viemed Healthcare (NASDAQ:VMD) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of Viemed Healthcare (NASDAQ:VMD) from a buy rating to a strong-buy rating in a research note published on Saturday.

Several other equities analysts have also issued reports on VMD. Zacks Research upgraded Viemed Healthcare to a “hold” rating in a research report on Thursday, January 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Viemed Healthcare in a research note on Monday, December 29th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock presently has a consensus rating of “Hold”.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $8.28 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.13 and a debt-to-equity ratio of 0.14. The stock has a market cap of $314.81 million, a PE ratio of 25.09 and a beta of 1.27. The company’s fifty day moving average is $7.53 and its 200 day moving average is $7.03. Viemed Healthcare has a 52 week low of $5.93 and a 52 week high of $8.94.

Institutional Investors Weigh In On Viemed Healthcare

A number of large investors have recently made changes to their positions in VMD. Walleye Capital LLC increased its stake in shares of Viemed Healthcare by 81.4% during the fourth quarter. Walleye Capital LLC now owns 24,963 shares of the company’s stock valued at $185,000 after buying an additional 11,200 shares during the period. State Street Corp boosted its holdings in Viemed Healthcare by 1.7% in the fourth quarter. State Street Corp now owns 675,190 shares of the company’s stock valued at $5,017,000 after acquiring an additional 11,385 shares in the last quarter. Martingale Asset Management L P increased its position in Viemed Healthcare by 6.0% during the 4th quarter. Martingale Asset Management L P now owns 42,483 shares of the company’s stock valued at $316,000 after purchasing an additional 2,399 shares during the period. Wells Fargo & Company MN increased its position in Viemed Healthcare by 74.7% during the 4th quarter. Wells Fargo & Company MN now owns 37,403 shares of the company’s stock valued at $278,000 after purchasing an additional 15,999 shares during the period. Finally, MetLife Investment Management LLC raised its holdings in Viemed Healthcare by 52.7% in the 4th quarter. MetLife Investment Management LLC now owns 18,565 shares of the company’s stock worth $138,000 after purchasing an additional 6,408 shares in the last quarter. 74.24% of the stock is currently owned by institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.